Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.
Duration: February 1, 2022
to
present
General Issues: Health Issues
Spending: about $90,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives
Affiliated organizations: Avalon Healthcare Solutions; Intermountain Healthcare; Invitae Corporation; Aegis Sciences Corporation
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Brett Meeks Former Deputy Health Policy Director for Senate Committee on Health, Education, Labor and Pensions
Former Deputy Health Policy Director for the Senate Committee on Health, Education, Labor and Pensions
Peter Dudziak n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on April 5.
Original Filing: 301546766.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on Jan. 17.
Original Filing: 301526566.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on Oct. 13, 2023.
Original Filing: 301500414.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on July 10, 2023.
Original Filing: 301474207.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on April 13, 2023.
Original Filing: 301451556.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023, H.R. 2369. Issues relating to value-based arrangements for lab testing.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on Jan. 1, 2023.
Original Filing: 301424444.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing. FDASLA Act of 2022, S. 4348.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on Oct. 6, 2022.
Original Filing: 301401750.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing. FDASLA Act of 2022, S. 4348.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on July 18, 2022.
Original Filing: 301382706.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing. FDASLA Act of 2022, S. 4348.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Horizon Government Affairs lobbied for Laboratory Access & Benefits (LAB) Coalition , earning $10,000. The report was filed on April 12, 2022.
Original Filing: 301345170.xml
Lobbying Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
Horizon Government Affairs filed a lobbying registration on March 4, 2022 to represent Laboratory Access & Benefits (LAB) Coalition, effective Feb. 1, 2022.
Original Filing: 301342227.xml
Issue(s) they said they’d lobby about: Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing, including for COVID-19 testing. Issues relating to the Protecting Access to Medicare Act and laboratory fee schedule. Regulation of laboratory-developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, S. 2209. Issues relating to value-based arrangements for lab testing. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...